Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$114.71
-0.9%
$146.73
$91.86
$254.15
$5.63B1.45922,095 shs1.52 million shs
Illumina, Inc. stock logo
ILMN
Illumina
$77.35
-0.3%
$82.02
$68.70
$156.66
$12.24B1.382.29 million shs1.42 million shs
Bio-Techne Co. stock logo
TECH
Bio-Techne
$50.24
-1.1%
$57.42
$46.01
$85.57
$7.94B1.451.22 million shs1.47 million shs
Waters Co. stock logo
WAT
Waters
$337.96
-0.8%
$355.96
$279.24
$423.56
$20.10B1.04475,445 shs252,623 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
-0.92%+8.33%-27.57%-30.43%-52.10%
Illumina, Inc. stock logo
ILMN
Illumina
-0.34%+8.62%-6.62%-43.22%-37.05%
Bio-Techne Co. stock logo
TECH
Bio-Techne
-1.06%+4.45%-15.39%-34.80%-20.91%
Waters Co. stock logo
WAT
Waters
-0.93%+5.32%-8.01%-17.76%+8.93%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
4.78 of 5 stars
4.02.00.04.73.53.31.9
Illumina, Inc. stock logo
ILMN
Illumina
4.6266 of 5 stars
4.24.00.04.22.31.71.3
Bio-Techne Co. stock logo
TECH
Bio-Techne
4.813 of 5 stars
4.23.01.74.22.02.51.9
Waters Co. stock logo
WAT
Waters
3.9247 of 5 stars
3.33.00.03.51.81.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
1.94
Reduce$182.0058.66% Upside
Illumina, Inc. stock logo
ILMN
Illumina
2.48
Hold$138.7079.31% Upside
Bio-Techne Co. stock logo
TECH
Bio-Techne
2.38
Hold$81.1461.51% Upside
Waters Co. stock logo
WAT
Waters
2.61
Moderate Buy$392.1316.03% Upside

Current Analyst Ratings Breakdown

Latest CRL, WAT, ILMN, and TECH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2025
Waters Co. stock logo
WAT
Waters
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$407.00 ➝ $355.00
4/16/2025
Waters Co. stock logo
WAT
Waters
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOutperform ➝ Outperform$400.00
4/10/2025
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$160.00 ➝ $145.00
4/10/2025
Illumina, Inc. stock logo
ILMN
Illumina
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$100.00 ➝ $77.00
4/10/2025
Waters Co. stock logo
WAT
Waters
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$400.00 ➝ $350.00
4/9/2025
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$175.00 ➝ $155.00
4/9/2025
Bio-Techne Co. stock logo
TECH
Bio-Techne
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Sector Weight
4/8/2025
Illumina, Inc. stock logo
ILMN
Illumina
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$128.00 ➝ $112.00
4/7/2025
Illumina, Inc. stock logo
ILMN
Illumina
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$90.00 ➝ $85.00
3/31/2025
Waters Co. stock logo
WAT
Waters
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Weight ➝ Overweight$460.00
3/26/2025
Waters Co. stock logo
WAT
Waters
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
(Data available from 4/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$4.05B1.39$15.34 per share7.48$67.80 per share1.69
Illumina, Inc. stock logo
ILMN
Illumina
$4.37B2.80$3.73 per share20.72$14.98 per share5.16
Bio-Techne Co. stock logo
TECH
Bio-Techne
$1.20B6.64$1.78 per share28.30$13.15 per share3.82
Waters Co. stock logo
WAT
Waters
$2.96B6.80$13.42 per share25.18$30.80 per share10.97
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$474.62M$0.15764.7310.434.540.52%14.69%6.79%5/7/2025 (Estimated)
Illumina, Inc. stock logo
ILMN
Illumina
-$1.22B-$7.68N/A14.991.60-27.95%13.37%5.49%5/8/2025 (Estimated)
Bio-Techne Co. stock logo
TECH
Bio-Techne
$168.10M$0.9950.7525.502.8813.22%12.73%9.75%4/29/2025 (Estimated)
Waters Co. stock logo
WAT
Waters
$637.83M$10.7131.5623.993.7921.56%46.31%15.67%5/6/2025 (Estimated)

Latest CRL, WAT, ILMN, and TECH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Illumina, Inc. stock logo
ILMN
Illumina
$0.94N/AN/AN/A$1.03 billionN/A
5/7/2025Q1 2025
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$2.06N/AN/AN/A$942.34 millionN/A
5/7/2025Q3 2025
Bio-Techne Co. stock logo
TECH
Bio-Techne
$0.52N/AN/AN/A$317.92 millionN/A
5/6/2025Q1 2025
Waters Co. stock logo
WAT
Waters
$2.22N/AN/AN/A$655.50 millionN/A
2/19/2025Q4 2024
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$2.50$2.66+$0.16-$4.22$983.63 million$1.00 billion
2/12/2025Q4 2024
Waters Co. stock logo
WAT
Waters
$4.02$4.10+$0.08$3.88$856.87 millionN/A
2/6/2025Q4 2024
Illumina, Inc. stock logo
ILMN
Illumina
$0.92$0.86-$0.06$1.17$1.08 billionN/A
2/5/2025Q2 2025
Bio-Techne Co. stock logo
TECH
Bio-Techne
$0.38$0.35-$0.03$0.22$285.84 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
N/AN/AN/AN/AN/A
Illumina, Inc. stock logo
ILMN
Illumina
N/AN/AN/AN/AN/A
Bio-Techne Co. stock logo
TECH
Bio-Techne
$0.320.64%N/A32.32%N/A
Waters Co. stock logo
WAT
Waters
N/AN/AN/AN/AN/A

Latest CRL, WAT, ILMN, and TECH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/5/2025
Bio-Techne Co. stock logo
TECH
Bio-Techne
quarterly$0.080.44%2/14/20252/17/20252/28/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
0.65
1.41
1.14
Illumina, Inc. stock logo
ILMN
Illumina
0.63
1.77
1.42
Bio-Techne Co. stock logo
TECH
Bio-Techne
0.14
3.94
2.77
Waters Co. stock logo
WAT
Waters
1.14
0.94
0.65

Institutional Ownership

CompanyInstitutional Ownership
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
98.91%
Illumina, Inc. stock logo
ILMN
Illumina
89.42%
Bio-Techne Co. stock logo
TECH
Bio-Techne
98.95%
Waters Co. stock logo
WAT
Waters
94.01%

Insider Ownership

CompanyInsider Ownership
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
1.30%
Illumina, Inc. stock logo
ILMN
Illumina
0.17%
Bio-Techne Co. stock logo
TECH
Bio-Techne
3.90%
Waters Co. stock logo
WAT
Waters
0.82%
CompanyEmployeesShares OutstandingFree FloatOptionable
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
21,40049.12 million50.47 millionOptionable
Illumina, Inc. stock logo
ILMN
Illumina
11,500158.26 million158.13 millionOptionable
Bio-Techne Co. stock logo
TECH
Bio-Techne
3,000158.09 million151.92 millionOptionable
Waters Co. stock logo
WAT
Waters
8,20059.50 million58.89 millionOptionable

Recent News About These Companies

Waters Co. stock logo
Mariner LLC Cuts Stock Position in Waters Co. (NYSE:WAT)
Waters Co. (NYSE:WAT) Receives $395.38 Consensus PT from Analysts

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Charles River Laboratories International stock logo

Charles River Laboratories International NYSE:CRL

$114.71 -1.05 (-0.91%)
Closing price 04/25/2025 03:59 PM Eastern
Extended Trading
$116.53 +1.82 (+1.59%)
As of 04/25/2025 07:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Illumina stock logo

Illumina NASDAQ:ILMN

$77.35 -0.26 (-0.34%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$77.44 +0.09 (+0.12%)
As of 04/25/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Bio-Techne stock logo

Bio-Techne NASDAQ:TECH

$50.24 -0.54 (-1.06%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$50.29 +0.05 (+0.10%)
As of 04/25/2025 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Waters stock logo

Waters NYSE:WAT

$337.96 -2.74 (-0.80%)
Closing price 04/25/2025 03:59 PM Eastern
Extended Trading
$334.54 -3.42 (-1.01%)
As of 04/25/2025 05:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.